- Home
- NRC vs LFCR Comparison
NRC vs LFCR Comparison
Compare NRC & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRC | LFCR |
|---|---|---|
| Founded | 1981 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 278.8M | 296.0M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NRC | LFCR |
|---|---|---|
| Price | $15.85 | $7.51 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 87.5K | ★ 156.2K |
| Earning Date | 01-26-2026 | 01-02-2026 |
| Dividend Yield | ★ 4.01% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.71 | N/A |
| Revenue | ★ $139,102,000.00 | $128,867,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | $22.35 | ★ N/A |
| Revenue Growth | N/A | ★ 0.47 |
| 52 Week Low | $9.76 | $4.76 |
| 52 Week High | $19.71 | $8.85 |
Technical Indicators
Market Signals| Indicator | NRC | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 52.77 | 51.36 |
| Support Level | $15.90 | $7.50 |
| Resistance Level | $16.53 | $7.87 |
| Average True Range (ATR) | 0.73 | 0.30 |
| MACD | -0.22 | -0.03 |
| Stochastic Oscillator | 17.93 | 36.14 |
Price Performance
Historical ComparisonAbout NRC National Research Corporation (Delaware)
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.